These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 17487849

  • 1. Screening for cervical cancer: controversy and contention or thoughtful analysis.
    Frable WJ.
    Cancer; 2007 Jun 25; 111(3):143-4. PubMed ID: 17487849
    [No Abstract] [Full Text] [Related]

  • 2. Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing.
    Schiffman M.
    Cancer; 2007 Jun 25; 111(3):145-53. PubMed ID: 17487850
    [Abstract] [Full Text] [Related]

  • 3. [Vaccination perspective against human papillomavirus and consequences for the screening of uterine cervical neoplasm].
    Delvenne P.
    Bull Mem Acad R Med Belg; 2007 Jun 25; 162(10-12):483-8; discussion 489-90. PubMed ID: 18557390
    [Abstract] [Full Text] [Related]

  • 4. Prevention of cervical cancer: where immunology meets diagnostics.
    Meijer CJ, Heideman DA, Berkhof H, Snijders PJ.
    Immunol Lett; 2009 Feb 21; 122(2):126-7. PubMed ID: 19100775
    [Abstract] [Full Text] [Related]

  • 5. Modern screening in cervical cancer. Perspectives of HPV prophylactic vaccines.
    Vlădăreanu R, Andrei C.
    Rev Med Chir Soc Med Nat Iasi; 2007 Feb 21; 111(1):144-54. PubMed ID: 17595860
    [Abstract] [Full Text] [Related]

  • 6. [Cervical carcinoma and the vaccination experience with Cervarix].
    Berberova M.
    Akush Ginekol (Sofiia); 2012 Feb 21; 51 Suppl 1():4-5. PubMed ID: 23236670
    [No Abstract] [Full Text] [Related]

  • 7. Papillomavirus vaccine types 16 and 18: new drug. Cervical cancer: just another vaccine.
    Prescrire Int; 2008 Jun 21; 17(95):103-4. PubMed ID: 18623911
    [Abstract] [Full Text] [Related]

  • 8. [Implementation of HPV vaccination in Germany].
    Schreckenberger C, Kaufmann AM, Schneider A.
    Dtsch Med Wochenschr; 2007 Oct 21; 132(42):2221-4. PubMed ID: 17926251
    [No Abstract] [Full Text] [Related]

  • 9. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
    Jenkins D.
    Gynecol Oncol; 2008 Sep 21; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
    [Abstract] [Full Text] [Related]

  • 10. Primary and secondary prevention of cervical cancer--opportunities and challenges.
    Markowitz LE, Unger ER, Saraiya M.
    J Natl Cancer Inst; 2009 Apr 01; 101(7):439-40. PubMed ID: 19318638
    [No Abstract] [Full Text] [Related]

  • 11. Screening: Testing times.
    Humphries C.
    Nature; 2012 Aug 30; 488(7413):S8-9. PubMed ID: 22932440
    [No Abstract] [Full Text] [Related]

  • 12. [Vaccination against human papillomavirus. Implementation and efficacy against cervical cancer control].
    Bégué P, Henrion R, Blanc B, Girard M, Sancho-Garnier H.
    Bull Acad Natl Med; 2007 Dec 30; 191(9):1805-16; discussion 1816-7. PubMed ID: 18663976
    [Abstract] [Full Text] [Related]

  • 13. Prevention of cervical cancer through vaccination of adolescents.
    Pichichero ME.
    Clin Pediatr (Phila); 2006 Jun 30; 45(5):393-8. PubMed ID: 16891270
    [No Abstract] [Full Text] [Related]

  • 14. [Vaccination against HPV in adults].
    Gil Á.
    Rev Esp Quimioter; 2009 Nov 30; 22 Suppl 1():22-5. PubMed ID: 20084345
    [No Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness of HPV 16, 18 vaccination in Brazil.
    Goldie SJ, Kim JJ, Kobus K, Goldhaber-Fiebert JD, Salomon J, O'shea MK, Xavier Bosch F, de Sanjosé S, Franco EL.
    Vaccine; 2007 Aug 14; 25(33):6257-70. PubMed ID: 17606315
    [Abstract] [Full Text] [Related]

  • 16. Quadrivalent human vaccine - a call to action and for additional research.
    Krogstad P, Cherry JD.
    Pediatr Res; 2007 Nov 14; 62(5):527. PubMed ID: 18049369
    [No Abstract] [Full Text] [Related]

  • 17. [Human papillomavirus infection. Screening, treatment and vaccination].
    Aubin F.
    Rev Prat; 2006 Nov 15; 56(17):1875-6. PubMed ID: 17243383
    [No Abstract] [Full Text] [Related]

  • 18. Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam.
    Domingo EJ, Noviani R, Noor MR, Ngelangel CA, Limpaphayom KK, Thuan TV, Louie KS, Quinn MA.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M71-9. PubMed ID: 18945416
    [Abstract] [Full Text] [Related]

  • 19. Towards global prevention of human papillomavirus-induced cancer.
    Roden RB, Gravitt P, Wu TC.
    Eur J Immunol; 2008 Feb 19; 38(2):323-6. PubMed ID: 18228245
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy of HPV 16/18 vaccines on sexually active young women and the impact on organized cervical cancer screening.
    Giorgi Rossi P, Zorzi M.
    Acta Obstet Gynecol Scand; 2010 Jun 19; 89(6):846-7; author reply 848. PubMed ID: 20504086
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.